Cash flows from operating activities: | |
Net loss | -70.23M |
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities: | |
Depreciation and accretion | 2.15M |
Amortization of intangible assets | 11.98M |
Stock-based compensation | 9.6M |
Interest expense on debt | |
Amortization of loan agreement costs | |
Non-cash foreign currency remeasurement (gain)/loss | 705K |
Impairment of prepaid royalties and guarantees | |
Changes in allowance for doubtful accounts | |
Changes in operating assets and liabilities: | |
Accounts receivable | 3.75M |
Prepaid royalties | |
Prepaid expenses and other assets | -1.15M |
Accounts payable | 674K |
Other accrued liabilities | |
Accrued compensation | 2.25M |
Accrued royalties | 748K |
Deferred revenues | 1.31M |
Accrued restructuring charge | 40K |
Other long-term liabilities | |
Net cash (used in)/provided by operating activities | |
Cash flows from investing activities: | |
Purchase of property and equipment | -1.7M |
Net cash used in investing activities | |
Cash flows from financing activities: | |
Proceeds from line of credit | |
Payments on line of credit | |
Net proceeds from Public Offering | |
MIG loan payments | |
Proceeds from exercise of warrants and issuance of common stock | |
Proceeds from exercise of stock options and ESPP | 2.16M |
Net cash provided by/(used in) in financing activities | |
Effect of exchange rate changes on cash | -263K |
Net increase/(decrease) in cash and cash equivalents | -33.03M |
Cash and cash equivalents at beginning of period | 180.54M |
Cash and cash equivalents at end of period | 147.52M |